We are live on ! Find out more
SVA

Sinovac Biotech, Ltd
SVA

Delisted

SVA was delisted on the 22nd of February, 2019.

Back to rankings

28 hedge funds and large institutions have $527M invested in Sinovac Biotech, Ltd in 2021 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

1% more capital invested

Capital invested by funds: $522M → $527M (+$4.85M)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

3% less funds holding

Funds holding: 29 → 28 (-1)

67% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 3

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

Holders
28
Holders Change
-1
Holders Change %
-3.45%
% of All Funds
0.49%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
–
Increased
1
Reduced
3
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$8.73K

Top Sellers

Rank Fund Capital Flow
1
FIM
Freedom Investment Management
Connecticut
-$110K
Name Holding Trade Value Shares
Change 		Change in
Stake
SA
1
SAIF Advisors
Hong Kong
$405M – – –
O
2
OrbiMed
New York
$76.8M – – –
VC
3
Vivo Capital
California
$38.2M – – –
NAH
4
Neumann Advisory (HK)
Hong Kong
$2.04M – – –
State Street
5
State Street
Massachusetts
$1.82M – – –
Renaissance Technologies
6
Renaissance Technologies
New York
$1.54M – – –
YMRC
7
Yorktown Management & Research Company
Virginia
$485K – – –
Skandinaviska Enskilda Banken (SEB)
8
Skandinaviska Enskilda Banken (SEB)
Sweden
$259K – – –
Geode Capital Management
9
Geode Capital Management
Massachusetts
$179K – – –
FIM
10
Freedom Investment Management
Connecticut
$116K -$110K -17,019 -49%
Susquehanna International Group
11
Susquehanna International Group
Pennsylvania
$106K – – –
UBS Group
12
UBS Group
Switzerland
$59K – – –
Northern Trust
13
Northern Trust
Illinois
$55K – – –
Morgan Stanley
14
Morgan Stanley
New York
$25K +$8.73K +1,341 +54%
JP Morgan Chase
15
JP Morgan Chase
New York
$19K – – –
FGAM
16
Financial Gravity Asset Management
Texas
$6K – – –
Group One Trading
17
Group One Trading
Illinois
$3K – – –
HI
18
Harbour Investments
Wisconsin
$1K – – –

SVA Hedge Fund Activity: Q2 2021 in Review

28 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Sinovac Biotech, Ltd (SVA) for Q2 2021, worth a combined $527M — up 0.93% from $522M a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of SVA and 0 opened new positions — a net loss of 1 holder — while 3 trimmed existing stakes and 1 added.

The largest buyer was Morgan Stanley, adding an estimated $8.73K. The largest seller was Freedom Investment Management, cutting an estimated $110K.

  • 28 institutional investors held Sinovac Biotech, Ltd (SVA) as of Q2 2021, down from 29 in Q1 2021.
  • Funds reported $527M of Sinovac Biotech, Ltd stock for Q2 2021, up 0.93% quarter-over-quarter.
  • 0 funds opened new Sinovac Biotech, Ltd positions in Q2 2021 and 1 closed out, a net change of -1 holder.
  • The largest Sinovac Biotech, Ltd buyer in Q2 2021 was Morgan Stanley, an estimated $8.73K added.
  • The largest Sinovac Biotech, Ltd seller in Q2 2021 was Freedom Investment Management, an estimated $110K sold.

Based on aggregated 13F filings for Q2 2021.